Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

Authors :: Rustin, Gordon J.S.
Quinn, Michael
Thigpen, Tate
Du Bois, Andreas
Pujade-Lauraine, Eric
Jakobsen, Anders
Eisenhauer, Elizabeth
Sagae, Satoru
Greven, Kathryn
Vergote, Ignace
Cervantes, Andres
Vermorken, Jan
Source :: JNCI: Journal of the National Cancer Institute. 3/17/2004, Vol. 96 Issue 6, p487-488. 2p.
Publication Year :: 2004
Abstract: Explains the Gynaecologic Cancer Intergroup's stand that definitions for response and progression of ovarian cancer according to serum CA 125 levels should be incorporated into ovarian cancer clinical trial protocols for relapse therapy. Definition of response; Rules for calculating CA 125 levels; Recommendation that CA 125 measurements be taken at specific time intervals.

Subjects :: *OVARIAN cancer
*CANCER treatment
*GYNECOLOGY
*CLINICAL trials
*TUMORS
*MEDICINE

Full Text Access

Tools